Sotuletinib (BLZ945)

规格	库存	目录价	会员专享价	数量
暂无牌价信息，您可以发送询价，我们会尽快给你回复。

规格

库存

目录价

会员专享价

数量

暂无牌价信息，您可以发送询价，我们会尽快给你回复。

基本信息

英文名称	Sotuletinib (BLZ945)
中文名称	Sotuletinib (BLZ945)
CAS号	953769-46-5
分子式	C20H22N4O3S
分子量	398.48
外观	Off-white to light brown powder
储存条件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

产品详情

Sotuletinib (formerly BLZ945; BLZ-945) is a novel, potent, selective, orally bioactive, and brain-penetrant CSF-1R (colony stimulating factor 1 receptor) inhibitor with potential antitumor activity. It exhibits 1000-fold higher selectivity against its closest receptor tyrosine kinase homologs and inhibits CSF-1R with an IC50 of 1 nM. Glioma-bearing mice demonstrate high in vivo antitumor efficaciousness of BLZ945. Sotuletinib was designated as an orphan drug by the US FDA in August 2022 in order to treat patients suffering from Amyotrophic Lateral Sclerosis (ALS), a progressive neurological disorder that affects nerve cells in the brain and spinal cord and results in loss of motor control.

Sotuletinib (BLZ945)

Sotuletinib (BLZ945)

化学品安全说明书(MSDS)